Voloridge Investment Management
XLRN

Voloridge Investment Management’s Acceleron Pharma XLRN Stock Holding History

Voloridge Investment Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-103,394
Closed -$17.8M – 1952
2021
Q3 		$17.8M Buy
+103,394
New +$13.5M 0.11% 236
2020
Q3 		– Sell
-21,546
Closed -$2.05M – 1571
2020
Q2 		$2.05M Buy
21,546
+12,023
+126% +$1.16M 0.02% 607
2020
Q1 		$856K Buy
+9,523
New +$740K 0.02% 554

Voloridge Investment Management's XLRN Position: Q4 2021 in Review

Voloridge Investment Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 103,394 shares — an estimated $17.8M sold.

Voloridge Investment Management first reported a position in XLRN in Q1 2020 and held it in 3 quarters. The position peaked at $17.8M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Voloridge Investment Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Voloridge Investment Management sold 103,394 Acceleron Pharma shares in Q4 2021, an estimated $17.8M.
  • Voloridge Investment Management first reported a position in Acceleron Pharma in Q1 2020 and held it in 3 quarters.
  • Voloridge Investment Management's Acceleron Pharma position peaked at $17.8M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Voloridge Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.